Open AccessImmunotherapy Combination Improves Survival in Advanced Colorectal Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000554326.96960.3d
Subject(s) - tremelimumab , microsatellite instability , colorectal cancer , immunotherapy , medicine , immune checkpoint , dna mismatch repair , oncology , population , cancer , durvalumab , blockade , cancer research , cancer immunotherapy , immunology , nivolumab , ipilimumab , biology , receptor , genetics , allele , environmental health , microsatellite , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom